Efficacy and Safety of Intracoronary Ad5FGF-4 in Patients With Stable Angina (AGENT-3)

NCT00346437 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

416

Enrollment

INDUSTRY

Sponsor class

Conditions

Angina Pectoris

Interventions

GENETIC: Ad5FGF-4 vs. Placebo

Sponsor

Cardium Therapeutics